Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid Nodules.

Mazeh H, Deutch T, Karas A, Bogardus KA, Mizrahi I, Gur-Wahnon D, Ben-Dov IZ.

Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):858-863. doi: 10.1158/1055-9965.EPI-18-0055. Epub 2018 Jul 26.

PMID:
30049841
2.

Urine cell-free microRNA as biomarkers for transitional cell carcinoma.

Geva GA, Gielchinsky I, Aviv N, Max KEA, Gofrit ON, Gur-Wahnon D, Ben-Dov IZ.

BMC Res Notes. 2017 Nov 29;10(1):641. doi: 10.1186/s13104-017-2950-9.

3.

Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance.

Khare D, Goldschmidt N, Bardugo A, Gur-Wahnon D, Ben-Dov IZ, Avni B.

PLoS One. 2017 Nov 13;12(11):e0187722. doi: 10.1371/journal.pone.0187722. eCollection 2017.

4.

Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.

Mizrahi A, Barzilai A, Gur-Wahnon D, Ben-Dov IZ, Glassberg S, Meningher T, Elharar E, Masalha M, Jacob-Hirsch J, Tabibian-Keissar H, Barshack I, Roszik J, Leibowitz-Amit R, Sidi Y, Avni D.

Oncogene. 2018 Jan 11;37(2):218-230. doi: 10.1038/onc.2017.315. Epub 2017 Sep 18.

PMID:
28925390
5.

Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).

Vaknin-Dembinsky A, Charbit H, Brill L, Abramsky O, Gur-Wahnon D, Ben-Dov IZ, Lavon I.

J Neuroinflammation. 2016 Jul 8;13(1):179. doi: 10.1186/s12974-016-0648-x.

6.

Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential.

Gur-Wahnon D, Mizrachi T, Wald-Altman S, Al-Roof Higazi A, Brenner T.

J Autoimmun. 2014 Aug;52:36-43. doi: 10.1016/j.jaut.2013.12.017. Epub 2014 Jan 11.

PMID:
24423642
7.

The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.

Gur-Wahnon D, Mizrachi T, Maaravi-Pinto FY, Lourbopoulos A, Grigoriadis N, Higazi AA, Brenner T.

J Neuroinflammation. 2013 Oct 11;10:124. doi: 10.1186/1742-2094-10-124.

8.

Novel CD47: SIRPα dependent mechanism for the activation of STAT3 in antigen-presenting cell.

Toledano N, Gur-Wahnon D, Ben-Yehuda A, Rachmilewitz J.

PLoS One. 2013 Sep 20;8(9):e75595. doi: 10.1371/journal.pone.0075595. eCollection 2013.

9.

The induction of APC with a distinct tolerogenic phenotype via contact-dependent STAT3 activation.

Gur-Wahnon D, Borovsky Z, Liebergall M, Rachmilewitz J.

PLoS One. 2009 Aug 31;4(8):e6846. doi: 10.1371/journal.pone.0006846.

10.

Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signaling.

Gur-Wahnon D, Borovsky Z, Beyth S, Liebergall M, Rachmilewitz J.

Exp Hematol. 2007 Mar;35(3):426-33.

PMID:
17309823
11.

Capicua integrates input from two maternal systems in Drosophila terminal patterning.

Cinnamon E, Gur-Wahnon D, Helman A, St Johnston D, Jiménez G, Paroush Z.

EMBO J. 2004 Nov 24;23(23):4571-82. Epub 2004 Oct 28.

Supplemental Content

Loading ...
Support Center